GlassScriptPhysician profile
Suhaib Bajwa
NPI 1861062192
$672.36
in general payments reported to CMS, 2019-2025
9 companies · $409 in 2025
The $409 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $88.73 · 2024: $175 · 2025: $409.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $365 · Education: $218.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $365.38 |
| Education | $218.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $203.47 | 2025 | Azure Xt Dr Mri Surescan, Cobalt Dr Mri Surescan, Omniasecure Mri Surescan |
| E.R. Squibb & Sons, L.L.C. | $160.62 | 2024-2025 | Camzyos |
| Abbott Laboratories | $115.08 | 2024-2025 | Ensite, Aveir |
| Glaxosmithkline, LLC. | $73.10 | 2022 | |
| Chiesi USA, INC. | $35.34 | 2022-2024 | Kengreal |
| Edwards Lifesciences Corporation | $34.09 | 2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Asahi Intecc USA, INC. | $22.17 | 2024 | Peripheral Vascular |
| Cordis US Corp. | $15.02 | 2025 | Mynx Control Venous |
| Novartis Pharmaceuticals Corporation | $13.47 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suhaib Bajwa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.